Literature DB >> 2881941

Predictors of tardive dyskinesia: results of a cross-sectional study in an outpatient population.

H Morgenstern, W M Glazer, L D Gibowski, S Holmberg.   

Abstract

A cross-sectional study was conducted to identify predictors of tardive dyskinesia (TD) in a group of 180 psychiatric outpatients maintained on neuroleptic medications. The estimated prevalence of this involuntary movement disorder was 33% in the total study population. Using multiple logistic regression, we found that TD was independently related to five factors: being 55 yr of age and older; being male; using depot (injectable) neuroleptics; having 6 or more years of neuroleptic exposure; and having less than 6 months of psychiatric hospitalization. In addition, the effect of depot medication was much greater in white males than it was in other race-sex groups. We observed no other interaction effects between pairs of predictor variables, nor did we find significant independent effects of race, denture use, DSM III diagnosis, current neuroleptic dose and potency, percent time on neuroleptics, and recent use of antiparkinsonian drugs or lithium. This study is serving as a pilot investigation for a large prospective incidence study that has already begun among patients at risk of developing TD in the same source population.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2881941     DOI: 10.1016/0021-9681(87)90047-6

Source DB:  PubMed          Journal:  J Chronic Dis        ISSN: 0021-9681


  5 in total

Review 1.  Tardive dyskinesia.

Authors:  T R Barnes
Journal:  Br Med J (Clin Res Ed)       Date:  1988-01-16

Review 2.  Drug-induced movement disorders.

Authors:  F J Jiménez-Jiménez; P J García-Ruiz; J A Molina
Journal:  Drug Saf       Date:  1997-03       Impact factor: 5.606

3.  Incidence of tardive dyskinesia with atypical versus conventional antipsychotic medications: a prospective cohort study.

Authors:  Scott W Woods; Hal Morgenstern; John R Saksa; Barbara C Walsh; Michelle C Sullivan; Roy Money; Keith A Hawkins; Ralitza V Gueorguieva; William M Glazer
Journal:  J Clin Psychiatry       Date:  2010-02-09       Impact factor: 4.384

4.  Tardive dystonia. Prevalence, risk factors and clinical features.

Authors:  M Raja; A Azzoni
Journal:  Ital J Neurol Sci       Date:  1996-12

Review 5.  Ethnic differences in the risks of adverse reactions to drugs used in the treatment of psychoses and depression: a systematic review and meta-analysis.

Authors:  Sara Ormerod; Sarah E McDowell; Jamie J Coleman; Robin E Ferner
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.